Mesoblast
MESO
$7.35
Share price
4.70%
Change (1 day)
92.41%
Change (1 year)
Categories
Market capitalization of Mesoblast (MESO)
Market cap: $0.83 Billion
As of May 2024 Mesoblast has a market cap of $0.83 Billion. This makes Mesoblast the world's 5416th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Mesoblast from 2008 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.83 B | 344.3% |
| 2023 | $0.18 B | -56.83% |
| 2022 | $0.43 B | -33.91% |
| 2021 | $0.66 B | -34.9% |
| 2020 | $1.01 B | 30.05% |
| 2019 | $0.78 B | 92.31% |
| 2018 | $0.40 B | -24.07% |
| 2017 | $0.53 B | 36.85% |
| 2016 | $0.39 B | -23.6% |
| 2015 | $0.51 B | -56.03% |
| 2014 | $1.16 B | -28.73% |
| 2013 | $1.63 B | 69.86% |
| 2012 | $0.96 B | -11.09% |
| 2011 | $1.08 B | 47.28% |
| 2010 | $0.73 B | 341.55% |
| 2009 | $0.16 B | 99.5% |
| 2008 | $83.38 M |
End of Day market cap according to different sources
On May 17th, 2024 the market cap of Mesoblast was reported to be:
$0.83 Billion
$0.83 Billion
$0.74 Billion
$0.84 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $18.25 M | -97.82% | Bahamas |
 NRC Health
NRC | $0.74 B | -11.76% | 🇺🇸 USA |